Our results also showed that markers of myocardial fibrosis (Mmp-2, ctgf, and Grem-1), cardiac hypertrophy (myl-2 and acta1), and profibrogenic transforming growth factor-β were regulated in diabetic hearts after myocardial infarction. The gene discussed is CCN2; the disease is cardiac hypertrophy.